InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Teehan Brendan, Dirigeant. Officer active across 1 companies, notably Acadia Pharmaceuticals INC. Aggregated, 4 filings have been logged. The latest transaction was filed on 23 February 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations4 total
1,567 shares
Common Stock
SEC:0001209191-22-026937:0·
01,106 shares0
Common Stock
SEC:0001209191-22-013284:0·
1,286 shares
Common Stock
SEC:0001209191-22-002751·
1,286 shares
Common Stock
SEC:0001209191-22-002751:0·
4 of 4 declarations
About Teehan Brendan
Brendan Teehan is EVP, COO, and Head of Commercial at Acadia Pharmaceuticals Inc. In this role, he is responsible for managing the company's operations and commercial strategy. His experience in the pharmaceutical sector enables him to lead initiatives aimed at improving the company's efficiency and profitability.
